SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-021358
Filing Date
2018-03-23
Accepted
2018-03-23 09:17:59
Documents
1
Period of Report
2018-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4869
  Complete submission text file 0001209191-18-021358.txt   6255
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 135 U.S. HIGHWAY 206 SUITE 15 BEDMINSTER NJ 07921
Business Address
Cagle Gerald D. (Reporting) CIK: 0001589991 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 18708524